Ownership of. Subject to the license grants to Moderna under this Agreement, as between the Parties, Merck will own and retain all right, title and interest in and to all [***]. Accordingly, Moderna will promptly disclose to Merck in writing, the conception, creation or discovery of any [***] by or on behalf of Moderna or its Affiliates. Moderna, for itself and on behalf of its Affiliates, hereby assigns (and to the extent such assignment can only be made in the future hereby agrees to assign), to Merck all its right, title and interest in and to any [***] conceived, created or discovered during the course of performing Collaboration Activities. Moderna will cooperate, and will cause the foregoing persons and entities to cooperate, with Merck to effectuate and perfect the foregoing ownership, including by promptly executing and recording assignments and other documents consistent with such ownership. To the extent that Moderna conceives, creates or discovers any [***] (solely or jointly with Merck) that is assigned to Merck pursuant to this Section 10.4, Merck hereby grants to Moderna a non-exclusive, royalty free and fully paid-up, sublicensable, worldwide license under such assigned [***], subject to Section 11, to research, develop, manufacture, use, commercialize, offer for sale, sell, distribute, import or export any product (or component thereof)
Ownership of. First Co-Development Effort” Joint Intellectual Property (JW-Type Package): Notwithstanding Section 2.4 above and unless otherwise agreed upon by the Parties in writing, all Joint Intellectual Property regarding the JW-Type Package referred to in Section 1.1 of this Agreement (collectively, “JW-Package Intellectual Property”) will be exclusively owned by GEM free and clear from any restrictions by AATI.
Ownership of. HAP Marker Associations. Genaissance shall have sole ownership of all right, title and interest in all HAP Marker Associations and, subject to Section 6.2(c), all HAP Marker Association Patent Rights, including without limitation Genaissance Collaboration IP. Sciona and its Affiliates shall disclose to Genaissance any HAP Marker Associations discovered solely by employees of Sciona or its Affiliates or others acting on their behalf. All information relating to such HAP Marker Associations shall be deemed the Confidential Information of Genaissance subject to the terms of Article 7, and Genaissance shall take all reasonable steps to maintain such information in confidence consistent with those steps taken to protect other information that Genaissance regards as proprietary or confidential and that is of similar value or importance. Sciona shall execute and deliver, without charge to Genaissance (other than reimbursement of Sciona’s reasonable out of pocket costs and expenses), assignment of all of its right, title and interest in and to HAP Marker Associations to Genaissance subject to Sciona’s right to use the HAP Marker Associations pursuant to the terms of this Agreement.
Ownership of. HAP Markers. Genaissance shall have sole ownership of all right, title and interest in all HAP Markers, and, subject to Section 6.2(c) all HAP Marker Patent Rights. Sciona and its Affiliates shall execute and deliver, without charge to Genaissance (other than reimbursement of Sciona’s reasonable out of pocket costs and expenses), assignment of all of its right, title and interest in and to HAP Markers to Genaissance subject to Sciona’s right to use the HAP Markers pursuant to the terms of this Agreement.
Ownership of. Technology and [***] Technology. Genmab shall during the Term of this Agreement and thereafter exclusively own all right, title and interest in and to the [***] Technology. Biontech shall during the Term of this Agreement and thereafter exclusively own all right, title and interest in and to the [***] Technology.
Ownership of. Unless otherwise provided in the applicable Statement of Work, Airspan will own all [***], and all IPRs in those [***], and such [***] will constitute Confidential Information of Airspan. Gogo hereby assigns and agrees to assign, by way of present assignment of existing and future rights, without further consideration, all right, title and interest in and to such [***] (including, without limitation, all IPRs therein), to Airspan, effective immediately upon the creation of such [***]. Airspan, its successors and assigns, will have the right to obtain and hold in its or their own name copyrights, registrations and any other protection available in the foregoing.
Ownership of. Environmental Engineering Science Publisher owns title and worldwide copyrights to Environmental Engineering Science (the “Journal”), including its contents and all print and electronic formats. Manuscripts submitted to the Journal by AEESP become the property of the Publisher upon publication; however, the author or AEESP may revise, adapt, prepare derivative works, present orally or otherwise make use of the contents of the articles submitted, provided that the Journal is acknowledged as the original source AEESP and author may utilize the contents of the Journal for non-commercial purposes to the extent permitted under principles of “fair use” pursuant to U.S. copyright law, including uses in connection with AEESP’s or author’s educational, research, and scholastic objectives provided that the Publisher grants its prior consent to such use, which consent shall not be unreasonably withheld, conditioned or delayed. No prior permission will be required for materials making up the AEESP Newsletter portion of the journal. This paragraph shall survive the termination of this Agreement.
Ownership of. IN Domain: NIXI shall be the sole owner of the data w.r.t .IN registry and shall have access to the as and when required.TSP shall enable access to NIXI or its agents to access the central systems to undertake queries as required by NIXI for audit, investigation or any other purpose. Mode and time of access will be intimated by NIXI to TSP in advance. Further, TSP will also develop certain specified queries on the database which can be accessed and run online by NIXI or its agents on periodic basis.